Apologies, but no results were found for the requested archive.
Recent Posts
- January, 2026
Recent FDA Updates: December 2025 – January 2026
HRP Consulting Group Welcomes Tamiko Eto
Unified USDA General Terms & Conditions of Awards Summary
Research Participant Payments – IRS Reporting Update. Summary and Sample Information Sheet
- December, 2025
Working with Vulnerable Populations
Summary DOJ NIH Rules on Sensitive Data Access
Sample IRB Guidelines for Investigators – Funding Agency Stop Work Orders
Comparison of FDA Regulations (Current and Proposed) & Common Rule
Summary of Proposed Changes – FDA Regulations 21 CFR 50, 21 CFR 56, and 21 CFR 812: Protection of Human Subjects and Institutional Review Boards
Update – Clinical Decision Support Software Final Guidance
New changes to NIH Guidance on Flexibilities for Conducting Semiannual Program Review and Inspections
Office of Research Integrity – Final Rule Updating the PHS Policies on Research Misconduct
FDA Proposed Rule: Investigational New Drug Applications: Exemptions for Clinical Investigations to Evaluate a Drug Use of a Product Lawfully Marketed as a Conventional Food, Dietary Supplement or Cosmetic
FDA Final Rule – Waiver or Alteration of Informed Consent for Minimal Risk Clinical Investigations
- February, 2025
Sample IRB Guidelines for Investigators – Funding Agency Stop Work Orders
- December, 2024
Understanding the Updated Final Rule on Research Misconduct: Key Changes and Institutional Impacts
- October, 2024
The Role of AI in Clinical Research: Boosting Efficiency and Addressing Compliance Challenges
Exception Process for Revised Common Rule Single IRB RequirementComparison of Common Rule_FDA_Revised FDA_May 2024Exception Process for Revised Common Rule Single IRB Requirement
- June, 2024
Navigating the Complexities of Exception from Informed Consent (EFIC) in Research
- January, 2026
Recent FDA Updates: December 2025 – January 2026
USDA General Terms & Conditions of Awards